These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6846326)

  • 61. Neutralization of the anticoagulant activity of low molecular weight heparin LU 47311 (Clivarin) in man by protamine chloride.
    Andrassy K; Eschenfelder V; Weber E
    Thromb Res; 1994 Jan; 73(2):85-93. PubMed ID: 8171416
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation.
    Fischer AM; Mauzac M; Tapon-Bretaudiere J; Jozefonvicz J
    Biomaterials; 1985 May; 6(3):198-202. PubMed ID: 2408688
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coagulant and noncoagulant thrombin enzymatic activity on the endothelium.
    Frebelius S; Nydahl S; Swedenborg J
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):285-92. PubMed ID: 2103313
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
    DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
    J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Study on neutralization of low molecular weight heparin (LHG) by protamine sulfate and its neutralization characteristics.
    Sugiyama T; Itoh M; Ohtawa M; Natsuga T
    Thromb Res; 1992 Oct; 68(2):119-29. PubMed ID: 1335615
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 69. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A method of determining heparin in blood plasma based on its antithrombin activity].
    Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI
    Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Does protamine chloride neutralize low molecular weight heparin sufficiently?
    Gram J; Mercker S; Bruhn HD
    Thromb Res; 1988 Dec; 52(5):353-9. PubMed ID: 2851882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coagulation protein function V: diminution of antithrombin III function by acetaldehyde.
    Brecher AS; Hellman K; Dulin C; Basista MH
    Dig Dis Sci; 1998 Aug; 43(8):1746-51. PubMed ID: 9724163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neutralization of thrombin by antithrombin III in the presence of cultured human fibroblasts.
    Brandt JT; Stephens RE; Hinkle GH
    Thromb Res; 1988 Jul; 51(2):187-96. PubMed ID: 2973155
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ostrich antithrombin III: kinetics and mechanism of inhibition of ostrich thrombin.
    Frost CL; Naudé RJ; Muramoto K
    Int J Biochem Cell Biol; 2002 Sep; 34(9):1164-71. PubMed ID: 12009311
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of pregnancy-associated plasma protein-A (PAPP-A) with coagulation: a bioassay for PAPP-A.
    Meisser A; Geinoz A; Bischof P
    Biol Reprod; 1985 Dec; 33(5):1073-7. PubMed ID: 2416361
    [TBL] [Abstract][Full Text] [Related]  

  • 76. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anticoagulant activity in cell-free peritoneal fluid of an experimental pancreatic ascites tumor.
    Ts'ao C; Galluzzo TS; Hart SJ; Ng AS; Sorenson PG; Subbarao V
    Thromb Haemost; 1985 Dec; 54(4):768-72. PubMed ID: 3003955
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2.
    Emadi S; Elalamy I; Vargaftig BB; Hatmi M
    Biochim Biophys Acta; 1996 May; 1300(3):226-32. PubMed ID: 8679688
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
    Simmons RB; Newton GR; Doctor VM
    Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.